General Dynamics Awarded U.S. Army Medical Research and Development Program Support Contract
November 20, 2017
FAIRFAX, Va. – General Dynamics Information Technology, a business unit of General Dynamics (NYSE: GD), was awarded the U.S. Army Medical Materiel Development Activity (USAMMDA) Strategic Support Services contract to provide support services for vaccine, drug and medical device research and development programs. The single-award, task order contract has a potential value of approximately $52 million for five years.
General Dynamics will provide programmatic, scientific, technical, logistical and administrative support for development requirements of medical products at the USAMMDA. Additionally, the company will help guide medical technologies through the U.S. Food and Drug Administration regulatory process and develop plans to bring the products into service. Work on the contract will be conducted at Fort Detrick in Frederick, Md.
“General Dynamics has extensive experience delivering a combination of health, military and IT services,” said Marcus Collier, senior vice president, Health and Civilian Solutions division, General Dynamics Information Technology. “We are committed to continuing our partnership with USAMMDA and assisting their mission of protecting and preserving the lives of warfighters.”
For more than 25 years, General Dynamics has been a trusted partner for the USAMMDA and delivered a range of services, including: information technology, program management, training, regulatory, scientific, technical and medical support.
For more information about General Dynamics Information Technology, please visit www.gdit.com.